Reduced TSPO binding in schizophrenia stands in contrast to increases in PET TSPO binding reported in several CNS inflammatory disorders with known pathologies involving microglial activation including stroke, multiple sclerosis, and Alzheimer’s and Huntington’s diseases. Here, TSPO is linked to stroke disorder.